STAT+: The revolving door swings again as Lupin hires an FDA official who oversaw problems at a key plant

The revolving door between the U.S. Food and Drug Administration and the pharmaceutical industry turned again this week when Lupin, one of India’s biggest drug companies, hired an agency official who oversaw manufacturing facilities, including a plant that has been cited for ongoing problems.

The company hired Diana Amador-Toro as senior vice president for global compliance after she spent more than 38 years working at the FDA, where she was most recently district director at the New Jersey office and also a division I director in the Office of Pharmaceutical Quality Operations.

Continue to STAT+ to read the full story…